158 related articles for article (PubMed ID: 32660395)
21. Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases.
Perez DI; Gil C; Martinez A
Med Res Rev; 2011 Nov; 31(6):924-54. PubMed ID: 20577972
[TBL] [Abstract][Full Text] [Related]
22. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
[TBL] [Abstract][Full Text] [Related]
23. Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1ε vs Casein Kinase 1δ.
Choi JY; Noguchi Y; Alburger JM; Bayle S; Chung E; Grant W; Chaikuad A; Knapp S; Duckett DR; Roush WR
J Med Chem; 2023 Jun; 66(11):7162-7178. PubMed ID: 37204207
[TBL] [Abstract][Full Text] [Related]
24. 2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors.
Hua Z; Huang X; Bregman H; Chakka N; DiMauro EF; Doherty EM; Goldstein J; Gunaydin H; Huang H; Mercede S; Newcomb J; Patel VF; Turci SM; Yan J; Wilson C; Martin MW
Bioorg Med Chem Lett; 2012 Sep; 22(17):5392-5. PubMed ID: 22877629
[TBL] [Abstract][Full Text] [Related]
25. Casein kinase I gamma subfamily. Molecular cloning, expression, and characterization of three mammalian isoforms and complementation of defects in the Saccharomyces cerevisiae YCK genes.
Zhai L; Graves PR; Robinson LC; Italiano M; Culbertson MR; Rowles J; Cobb MH; DePaoli-Roach AA; Roach PJ
J Biol Chem; 1995 May; 270(21):12717-24. PubMed ID: 7759525
[TBL] [Abstract][Full Text] [Related]
26. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
[TBL] [Abstract][Full Text] [Related]
27. Casein kinase 1α has a non-redundant and dominant role within the CK1 family in melanoma progression.
Sinnberg T; Wang J; Sauer B; Schittek B
BMC Cancer; 2016 Aug; 16():594. PubMed ID: 27488834
[TBL] [Abstract][Full Text] [Related]
28. Small molecule modulators targeting protein kinase CK1 and CK2.
Qiao Y; Chen T; Yang H; Chen Y; Lin H; Qu W; Feng F; Liu W; Guo Q; Liu Z; Sun H
Eur J Med Chem; 2019 Nov; 181():111581. PubMed ID: 31400711
[TBL] [Abstract][Full Text] [Related]
29. The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis.
Knippschild U; Krüger M; Richter J; Xu P; García-Reyes B; Peifer C; Halekotte J; Bakulev V; Bischof J
Front Oncol; 2014; 4():96. PubMed ID: 24904820
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.
Allocco JJ; Donald R; Zhong T; Lee A; Tang YS; Hendrickson RC; Liberator P; Nare B
Int J Parasitol; 2006 Oct; 36(12):1249-59. PubMed ID: 16890941
[TBL] [Abstract][Full Text] [Related]
31. Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta.
Calenda S; Catarzi D; Varano F; Vigiani E; Volpini R; Lambertucci C; Spinaci A; Trevisan L; Grieco I; Federico S; Spalluto G; Novello G; Salmaso V; Moro S; Colotta V
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675428
[TBL] [Abstract][Full Text] [Related]
32. A novel consensus phosphorylation motif in sulfatide- and cholesterol-3-sulfate-binding protein substrates for CK1 in vitro.
Kawakami F; Suzuki K; Ohtsuki K
Biol Pharm Bull; 2008 Feb; 31(2):193-200. PubMed ID: 18239272
[TBL] [Abstract][Full Text] [Related]
33. CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders.
Baier A; Szyszka R
Front Mol Biosci; 2022; 9():916063. PubMed ID: 36275622
[TBL] [Abstract][Full Text] [Related]
34. Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).
Xu P; Ianes C; Gärtner F; Liu C; Burster T; Bakulev V; Rachidi N; Knippschild U; Bischof J
Gene; 2019 Oct; 715():144005. PubMed ID: 31376410
[TBL] [Abstract][Full Text] [Related]
35. Intracellular trafficking of a polymorphism in the COOH terminus of the alpha-subunit of the human epithelial sodium channel is modulated by casein kinase 1.
Yan W; Spruce L; Rosenblatt MM; Kleyman TR; Rubenstein RC
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F868-76. PubMed ID: 17596527
[TBL] [Abstract][Full Text] [Related]
36. CK1 in Developmental Signaling: Hedgehog and Wnt.
Jiang J
Curr Top Dev Biol; 2017; 123():303-329. PubMed ID: 28236970
[TBL] [Abstract][Full Text] [Related]
37. Characterization of two T. gondii CK1 isoforms.
Donald RG; Zhong T; Meijer L; Liberator PA
Mol Biochem Parasitol; 2005 May; 141(1):15-27. PubMed ID: 15811523
[TBL] [Abstract][Full Text] [Related]
38. Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization.
Yang LL; Li GB; Yan HX; Sun QZ; Ma S; Ji P; Wang ZR; Feng S; Zou J; Yang SY
Eur J Med Chem; 2012 Oct; 56():30-8. PubMed ID: 22944772
[TBL] [Abstract][Full Text] [Related]
39. A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1ε.
Dolde C; Bischof J; Grüter S; Montada A; Halekotte J; Peifer C; Kalbacher H; Baumann U; Knippschild U; Suter B
J Cell Sci; 2018 Jan; 131(1):. PubMed ID: 29222110
[TBL] [Abstract][Full Text] [Related]
40. The protein kinase CK1: Inhibition, activation, and possible allosteric modulation.
Sunkari YK; Meijer L; Flajolet M
Front Mol Biosci; 2022; 9():916232. PubMed ID: 36090057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
